Suppr超能文献

噻唑烷二酮依赖性Jurkat T细胞死亡的机制

Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.

作者信息

Soller Mathias, Dröse Stefan, Brandt Ulrich, Brüne Bernhard, von Knethen Andreas

机构信息

Department of Biochemistry I-Pathobiochemistry, Johann Wolfgang Goethe University, Faculty of Medicine, Frankfurt, Main, Germany.

出版信息

Mol Pharmacol. 2007 Jun;71(6):1535-44. doi: 10.1124/mol.107.034371. Epub 2007 Feb 26.

Abstract

Thiazolidinediones are synthetic agonists for the transcription factor peroxisome proliferator-activated receptor gamma (PPARgamma) and are therapeutically used as insulin sensitizers. Besides therapeutical benefits, potential side effects such as the induction of cell death by thiazolidinediones deserve consideration. Although PPARgamma-dependent and -independent cell death in response to thiazolidinediones has been described, we provide evidence supporting a new mechanism to account for thiazolidinedione-initiated but PPARgamma-independent cell demise. In Jurkat T cells, ciglitazone and troglitazone provoked rapid and dose-dependent cell death, whereas rosiglitazone did not alter cell viability. We found induction of apoptosis by troglitazone, whereas ciglitazone caused necrosis. Because preincubation with the reactive oxygen species (ROS) scavengers manganese (III) tetrakis(4-benzoic acid) porphyrin and vitamin C significantly inhibited ciglitazone- and partially troglitazone-mediated cell death, we suggest that ROS contribute to cytotoxicity. Assuming that ROS originate from mitochondria, studies in submitochondrial particles demonstrated that all thiazolidinediones inhibited complex I of the mitochondrial respiratory chain. However, only ciglitazone and troglitazone lowered complex II activity as well. Pharmacological inhibition of complexes I and II documented that complex II inhibition in Jurkat cells caused massive apoptotic cell death, whereas inhibition of complex I provoked only marginally apoptosis after 4-h treatment. Therefore, inhibition of complex II by ciglitazone and troglitazone is the main trigger of cell death. ATP depletion by ciglitazone, in contrast to troglitazone, is responsible for induction of necrosis. Our results demonstrate that despite their similar molecular structure, thiazolidinediones differently affect cell death, which might help to explain some adverse effects occurring during thiazolidinedione-based therapies.

摘要

噻唑烷二酮类药物是转录因子过氧化物酶体增殖物激活受体γ(PPARγ)的合成激动剂,在治疗上用作胰岛素增敏剂。除了治疗益处外,噻唑烷二酮类药物诱导细胞死亡等潜在副作用也值得关注。尽管已经描述了噻唑烷二酮类药物引起的PPARγ依赖性和非依赖性细胞死亡,但我们提供的证据支持一种新机制,以解释噻唑烷二酮类药物引发的但PPARγ非依赖性的细胞死亡。在Jurkat T细胞中,吡格列酮和曲格列酮引发快速且剂量依赖性的细胞死亡,而罗格列酮未改变细胞活力。我们发现曲格列酮诱导细胞凋亡,而吡格列酮导致细胞坏死。由于用活性氧(ROS)清除剂锰(III)四(4 - 苯甲酸)卟啉和维生素C预孵育可显著抑制吡格列酮和部分抑制曲格列酮介导的细胞死亡,我们认为ROS促成了细胞毒性。假设ROS源自线粒体,对亚线粒体颗粒的研究表明,所有噻唑烷二酮类药物均抑制线粒体呼吸链复合体I。然而,只有吡格列酮和曲格列酮也降低了复合体II的活性。对复合体I和II的药理学抑制表明,Jurkat细胞中复合体II的抑制导致大量凋亡性细胞死亡,而复合体I的抑制在4小时处理后仅引发轻微凋亡。因此,吡格列酮和曲格列酮对复合体II的抑制是细胞死亡的主要触发因素。与曲格列酮不同,吡格列酮导致的ATP耗竭是坏死诱导的原因。我们的结果表明,尽管噻唑烷二酮类药物具有相似的分子结构,但它们对细胞死亡的影响不同,这可能有助于解释基于噻唑烷二酮类药物的治疗过程中出现的一些不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验